Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02523014
Recruitment Status : Suspended (No arms are currently open to patient registration)
First Posted : August 14, 2015
Last Update Posted : February 5, 2020
National Cancer Institute (NCI)
Genentech, Inc.
Brain Science Foundation
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : August 2021
Study Completion Date : No date given